Public Employees Retirement Association of Colorado cut its position in Stryker Co. (NYSE:SYK) by 1.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 61,460 shares of the medical technology company’s stock after selling 1,113 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Stryker were worth $12,635,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of SYK. D.B. Root & Company LLC increased its position in shares of Stryker by 3.0% during the second quarter. D.B. Root & Company LLC now owns 1,724 shares of the medical technology company’s stock worth $354,000 after acquiring an additional 50 shares in the last quarter. Independence Bank of Kentucky increased its position in shares of Stryker by 4.9% during the first quarter. Independence Bank of Kentucky now owns 1,180 shares of the medical technology company’s stock worth $233,000 after acquiring an additional 55 shares in the last quarter. Benedict Financial Advisors Inc. increased its position in shares of Stryker by 1.1% during the first quarter. Benedict Financial Advisors Inc. now owns 5,235 shares of the medical technology company’s stock worth $1,034,000 after acquiring an additional 57 shares in the last quarter. Berman Capital Advisors LLC increased its position in shares of Stryker by 11.1% during the first quarter. Berman Capital Advisors LLC now owns 571 shares of the medical technology company’s stock worth $112,000 after acquiring an additional 57 shares in the last quarter. Finally, Bailard Inc. increased its position in shares of Stryker by 0.6% during the second quarter. Bailard Inc. now owns 9,219 shares of the medical technology company’s stock worth $1,895,000 after acquiring an additional 57 shares in the last quarter. Institutional investors own 73.48% of the company’s stock.

Shares of SYK opened at $212.06 on Thursday. The company has a 50-day moving average price of $210.23. Stryker Co. has a one year low of $144.75 and a one year high of $222.59. The company has a market cap of $81.21 billion, a P/E ratio of 29.01, a PEG ratio of 2.64 and a beta of 0.85. The company has a current ratio of 2.07, a quick ratio of 1.26 and a debt-to-equity ratio of 0.67.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 25th. The medical technology company reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.05. Stryker had a net margin of 24.99% and a return on equity of 25.98%. The company had revenue of $3.65 billion during the quarter, compared to the consensus estimate of $3.60 billion. During the same quarter last year, the firm posted $1.76 EPS. The company’s quarterly revenue was up 9.9% on a year-over-year basis. As a group, analysts expect that Stryker Co. will post 8.2 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Monday, September 30th will be paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Friday, September 27th. Stryker’s dividend payout ratio is presently 28.45%.

Several brokerages have recently issued reports on SYK. Barclays set a $226.00 price objective on shares of Stryker and gave the stock a “buy” rating in a research report on Friday, July 26th. Morgan Stanley raised their target price on shares of Stryker from $218.00 to $230.00 and gave the company an “overweight” rating in a research report on Tuesday, July 16th. Zacks Investment Research raised shares of Stryker from a “hold” rating to a “buy” rating and set a $225.00 target price for the company in a research report on Monday, July 29th. Oppenheimer raised their target price on shares of Stryker from $183.00 to $192.00 and gave the company an “outperform” rating in a research report on Wednesday, April 24th. Finally, Deutsche Bank raised their target price on shares of Stryker from $181.00 to $208.00 and gave the company a “buy” rating in a research report on Wednesday, April 24th. Five investment analysts have rated the stock with a hold rating and nineteen have issued a buy rating to the stock. Stryker has an average rating of “Buy” and a consensus target price of $214.89.

In other news, Director Allan C. Golston sold 3,399 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $209.84, for a total transaction of $713,246.16. Following the completion of the sale, the director now owns 13,762 shares in the company, valued at approximately $2,887,818.08. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Timothy J. Scannell sold 4,666 shares of the firm’s stock in a transaction dated Tuesday, July 16th. The stock was sold at an average price of $205.88, for a total transaction of $960,636.08. Following the sale, the insider now owns 155,963 shares of the company’s stock, valued at approximately $32,109,662.44. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,431 shares of company stock valued at $3,174,489. 7.20% of the stock is currently owned by corporate insiders.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Further Reading: What is Forex?

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.